Key points are not available for this paper at this time.
Selecting omic biomarkers using both their effect size and their differential status significance (i.e., selecting the "volcano-plot outer spray") has long been equally biologically relevant and statistically troublesome. However, recent proposals are paving the way to resolving this dilemma.
Thomas Bürger (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: